Adverse effects of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin therapy in patients with hepatitis C virus genotype 1/4 infection: Real-life experience in Turkey


AYGEN B. , DEMİRTÜRK N., YILDIZ O. , ÇELEN M. K. , ÇELİK İ., BARUT H. Ş. , ...More

28th Annual Conference Acian Pacific Association for the Study of the Liver, 20 - 24 February 2019

  • Publication Type: Conference Paper / Summary Text